Pulsed Intravenous Cyclophosphamide for Severe Ocular Inflammatory Disease: An International Experience

Journal Title: Journal of Ocular Biology - Year 2015, Vol 3, Issue 1

Abstract

Study background: The purpose of this study is to assess the clinical response of intravenous pulses of cyclophosphamide for severe ocular inflammation. Methods: This is an observational and retrospective clinical study, with inclusion of all the patients with severe ocular inflammatory diseases treated with pulsed intravenous cyclophosphamide. The data obtained from the medical records included general information, initial and final best-corrected visual acuity, complications, previous therapy and time of follow-up. We assessed inflammation according to the ocular manifestation for outcome analysis. Clinical improvement and the corticosteroid-sparing effect were evaluated. Results: Twenty-one patients were included (32 eyes) with a median age of 57 years. The most common ocular diagnosis was necrotizing scleritis. The median number of pulses of cyclophosphamide was 3 (range 1 to 12 pulses). Eighteen patients (85.7%) attained clinical improvement, and twenty patients (95.2%) achieved reduction in the corticosteroid dose after the treatment with cyclophosphamide. Fourteen patients (66.6%) gained two or more lines of vision, with a median final best-corrected visual acuity of 20/40. Six patients (28.5%) presented adverse effects attributed to the cyclophosphamide. The median time of follow-up was 8 months (range 3 – 19 months). Conclusion: The use of intravenous pulses of cyclophosphamide in ocular inflammatory disease could be used with good results including clinical and visual improvement, and with a high rate in reduction in the corticosteroid dose.

Authors and Affiliations

Miguel Pedroza-Seres

Keywords

Related Articles

Upregulation of GADD45α, TP53 and CASP3 mRNA Expression in the Rat Lens after In vivo Exposure to Sub-threshold Dose of UVR B

Purpose: The objective of the present study was to investigate the evolution of mRNA expression of the stress sensor GADD45α, the apoptosis initiator TP53 and the apoptosis executor CASP3 in the rat lens after in vivo ex...

Massive Extraorbital Extension in a Recurring Untreated Retinoblastoma: A Rare Case from Lebanon

Orbital retinoblastoma usually carries a dismal prognosis. We describe a case of a 2 year old boy with a massive extraorbital recurrent unilateral retinoblastoma that was operated previously at 4 months of age. As a cons...

Regulation of Adherens Junctions in Trabecular Meshwork Cells by Rac GTPase and their influence on Intraocular Pressure

Intercellular adherens junctions and cell-extracellular matrix interactions are presumed to influence aqueous humor (AH) drainage via the conventional route, however, their direct role in modulation of intraocular pressu...

Valsalva Retinopathy Associated with Choking and Heimlich Maneuver

Valsalva is “a particular form of retinopathy, pre-retinal and hemorrhagic in nature, secondary to a sudden increase in intrathoracic pressure”. Increasing intrathoracic pressure against a closed glottis diminishes venou...

A Mouse Model of Multi-DrugResistant Staphylococcus aureus-induced Ocular Disease

Staphylococcus aureus infection of the cornea is a significant threat to vision. The percentage of bacterial isolates resistant to antibiotics is increasing as is the percentage of infections caused by methicillin resist...

Download PDF file
  • EP ID EP197796
  • DOI 10.13188/2334-2838.1000019
  • Views 96
  • Downloads 0

How To Cite

Miguel Pedroza-Seres (2015). Pulsed Intravenous Cyclophosphamide for Severe Ocular Inflammatory Disease: An International Experience. Journal of Ocular Biology, 3(1), 1-3. https://europub.co.uk./articles/-A-197796